Endo Announces Resolution of Government Investigation - San Diego, California News Station - KFMB Channel 8 - cbs8.com

Endo Announces Resolution of Government Investigation

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Endo Pharmaceuticals

MALVERN, Pa., Feb. 21, 2014 /PRNewswire/ -- Endo Pharmaceuticals, a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), announced today that it has reached a resolution of criminal and civil claims with the federal and participating state authorities and the District of Columbia regarding a previously disclosed investigation concerning past US sales, marketing and promotional practices related to Endo Pharmaceuticals Inc. product Lidoderm®.  Under the agreement, the company will pay a total of up to a previously reserved $194 million

As a part of the settlement, Endo has entered into a Deferred Prosecution Agreement (DPA) with the  United States Department of Justice (DOJ)  for a period of up to 2 ½ years and a Corporate Integrity Agreement (CIA) with the United States Department of Health and Human Services, Office of Inspector General (HHS-OIG) for a period of (5) years. The agreements build on Endo's existing comprehensive compliance programs. 

"The company takes its responsibility to patients, healthcare providers and our shareholders very seriously," said Endo's president and chief executive officer, Rajiv De Silva.  "We are pleased to resolve this matter and are confident that we have robust programs in place to assist us in satisfying our legal and regulatory agreements. We are committed to a company culture that supports the conduct of our business in a compliant and ethical manner."  

About Endo Pharmaceuticals Inc.

Endo Pharmaceuticals Inc., headquartered in Malvern, PA, is focused on developing and delivering high-value branded pharmaceutical products that meet the unmet needs of patients.  The company is currently focused in the areas of Pain Management, Urology, and Endocrinology.  Endo Pharmaceuticals is an operating company of Endo Health Solutions Inc. (NASDAQ: ENDP),  a specialty healthcare company with segments focused on branded pharmaceuticals, generics, and medical devices, each providing quality products to customers intended to improve the lives of patients. Learn more at www.endo.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements.  Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" in our Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein or therein, could affect our future financial results and could cause our actual results to differ materially from those expressed in forward-looking statements contained in our Annual Report on Form 10-K. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause our actual results to differ materially from expected and historical results. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

©2012 PR Newswire. All Rights Reserved.

  • PoliticsMore>>

  • Late sign-ups improve outlook for Obama health law

    Late sign-ups improve outlook for Obama health law

    Friday, April 18 2014 11:10 AM EDT2014-04-18 15:10:20 GMT
    A surge of eleventh-hour enrollments has improved the outlook for President Barack Obama's health care law, with more people signing up overall and a much-needed spark of interest  
    A surge of eleventh-hour enrollments has improved the outlook for President Barack Obama's health care law, with more people signing up overall and a much-needed spark of interest among young adults. 
  • Obama: 8 million signed up for health care

    Obama: 8 million signed up for health care

    Thursday, April 17 2014 11:22 PM EDT2014-04-18 03:22:47 GMT
    Eight million people have signed up for health care through new insurance exchanges and the proportion of younger applicants has increased, President Barack Obama said Thursday. 
    Eight million people have signed up for health care through new insurance exchanges and the proportion of younger applicants has increased, President Barack Obama said Thursday. 
  • Obama, Biden announce $600M for job grants

    Obama, Biden announce $600M for job grants

    Wednesday, April 16 2014 11:30 PM EDT2014-04-17 03:30:15 GMT
    Emphasizing skills training as key to a growing middle class, President Barack Obama on Wednesday announced $600 million in competitive grants to spur creation of targeted training and apprenticeship programs. 
    Emphasizing skills training as key to a growing middle class, President Barack Obama on Wednesday announced $600 million in competitive grants to spur creation of targeted training and apprenticeship programs to help people land good-paying jobs. 
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Midwest Television, Inc. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.